Chapter 21 – SYSTEMIC LUPUS ERYTHEMATOSUS

[1]  Morel Ayala Zoilo,et al.  Chronic inflammatory demyelinating polyradiculoneuropathy in a boy with systemic lupus erythematosus , 2010, Rheumatology International.

[2]  R. González-Amaro,et al.  Rituximab in systemic lupus erythematosus , 2010, Lupus.

[3]  D. Gipson,et al.  Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[4]  C. Gordon,et al.  Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. , 2009, Rheumatology.

[5]  M. Goodfield,et al.  Scar classification in cutaneous lupus erythematosus: morphological description , 2009, The British journal of dermatology.

[6]  E. Silverman,et al.  Ethnic Differences in Pediatric Systemic Lupus Erythematosus , 2009, The Journal of Rheumatology.

[7]  A. Marzano,et al.  Drug-induced lupus: an update on its dermatologic aspects , 2009, Lupus.

[8]  E. Silverman,et al.  Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. , 2009, Arthritis and rheumatism.

[9]  C. Duarte,et al.  White Blood Cell Count Abnormalities and Infections in One‐year Follow‐up of 124 Patients with SLE , 2009, Annals of the New York Academy of Sciences.

[10]  B. Ni,et al.  Upregulated BclG(L) expression enhances apoptosis of peripheral blood CD4+ T lymphocytes in patients with systemic lupus erythematosus. , 2009, Clinical immunology.

[11]  F. Dammacco,et al.  Oversecretion of Cytokines and Chemokines in Lupus Nephritis Is Regulated by Intraparenchymal Dendritic Cells , 2009, Annals of the New York Academy of Sciences.

[12]  E. McNeil,et al.  Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  Su-xia Wang,et al.  Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. , 2009, Kidney international.

[14]  R. Moots,et al.  The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[15]  Li-Chen Chen,et al.  Mesenteric vasculitis as the initial presentation in children with systemic lupus erythematosus. , 2009, Journal of pediatric gastroenterology and nutrition.

[16]  Anselm Mak,et al.  Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression. , 2009, Rheumatology.

[17]  M. Ramos-Casals,et al.  Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases , 2009, Lupus.

[18]  E. Cholongitas,et al.  Deforming arthropathy in SLE: review in the literature apropos of one case , 2009, Rheumatology International.

[19]  G. Ruiz-Irastorza,et al.  Predictors of major infections in systemic lupus erythematosus , 2009, Arthritis research & therapy.

[20]  R. Karas,et al.  Association between statin-associated myopathy and skeletal muscle damage , 2009, Canadian Medical Association Journal.

[21]  Z. El-Sayed,et al.  Cardiovascular autonomic function assessed by autonomic function tests and serum autonomic neuropeptides in Egyptian children and adolescents with rheumatic diseases. , 2009, Rheumatology.

[22]  C. Silva,et al.  Autoimmune hepatitis and juvenile systemic lupus erythematosus , 2009, Lupus.

[23]  M. Punaro,et al.  Health-related Quality of Life and Its Relationship to Patient Disease Course in Childhood-onset Systemic Lupus Erythematosus , 2009, The Journal of Rheumatology.

[24]  D. Vital-Durand,et al.  Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus. , 2009, Rheumatology.

[25]  M. Hoylaerts,et al.  Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome , 2009, European journal of haematology.

[26]  D. Jain,et al.  Cardiac pathology of systemic lupus erythematosus , 2009, Journal of Clinical Pathology.

[27]  J. Reveille,et al.  Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. , 2009, Arthritis and rheumatism.

[28]  Lingyun Sun,et al.  Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans , 2009, Stem cells.

[29]  D. Gladman,et al.  The 1000 Canadian Faces of Lupus: Determinants of Disease Outcome in a Large Multiethnic Cohort , 2009, The Journal of Rheumatology.

[30]  Y. Inoue,et al.  Self‐limited lupus‐like presentation of human parvovirus B19 infection in a 1‐year‐old girl , 2009, Pediatrics international : official journal of the Japan Pediatric Society.

[31]  P. Moses,et al.  Acute pancreatitis as the initial presentation in pediatric systemic lupus erythematosus , 2009, Indian journal of pediatrics.

[32]  Don L. Armstrong,et al.  Identification of new SLE-associated genes with a two-step Bayesian study design , 2009, Genes and Immunity.

[33]  A. Reiff,et al.  Relationship between health-related quality of life and SLE activity and damage in children over time , 2009, Lupus.

[34]  Sung-Hwan Park,et al.  Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea , 2009, Lupus.

[35]  E. Krebs,et al.  The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review , 2009, Lupus.

[36]  Y. Shoenfeld,et al.  Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". , 2009, Journal of autoimmunity.

[37]  T. Takano,et al.  Acquired activated protein C resistance is associated with IgG antibodies to protein S in patients with systemic lupus erythematosus. , 2009, Thrombosis research.

[38]  P. Miettunen,et al.  Dramatic Response of Scarring Scalp Discoid Lupus Erythematosus (DLE) to Intravenous Methylprednisolone, Oral Corticosteroids, and Hydroxychloroquine in a 5‐Year‐Old Child , 2009, Pediatric dermatology.

[39]  D. Isenberg,et al.  Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. , 2009, Journal of the American Society of Nephrology : JASN.

[40]  Jun Ying,et al.  Initial Validation of a Novel Protein Biomarker Panel for Active Pediatric Lupus Nephritis , 2009, Pediatric Research.

[41]  S. Appenzeller,et al.  Acute acalculous cholecystitis in juvenile systemic lupus erythematosus , 2009, Lupus.

[42]  J. Perry,et al.  Acute Myocardial Infarction as the Presenting Symptom of Systemic Lupus Erythematosus , 2009, Pediatric Cardiology.

[43]  G. Illei,et al.  Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. , 2009, Journal of the American Society of Nephrology : JASN.

[44]  M. Yamazaki-Nakashimada,et al.  Intestinal pseudoobstruction associated with eosinophilic enteritis as the initial presentation of systemic lupus erythematosus in children. , 2009, Journal of pediatric gastroenterology and nutrition.

[45]  C. Mok.  Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma , 2009, Nature Reviews Nephrology.

[46]  R. Muche,et al.  Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings. , 2009, Family practice.

[47]  Don L. Armstrong,et al.  High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. , 2009, Arthritis and rheumatism.

[48]  J. Ahluwalia,et al.  Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India , 2009, Rheumatology International.

[49]  S. Salah,et al.  Systemic lupus erythematosus in Egyptian children , 2009, Rheumatology International.

[50]  G. Herrero-Beaumont,et al.  Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility , 2009, Arthritis research & therapy.

[51]  A. Bagga,et al.  Outcome of lupus nephritis in Indian children , 2009, Lupus.

[52]  G. Appel,et al.  An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases , 2009, Nature Clinical Practice Nephrology.

[53]  Kenneth G. C. Smith,et al.  European consensus statement on the terminology used in the management of lupus glomerulonephritis , 2009, Lupus.

[54]  M. Ermani,et al.  Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. , 2009, Journal of autoimmunity.

[55]  C. Elie,et al.  Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[56]  H. Nazif,et al.  Antineuronal antibodies and electroneurophysiological studies in pediatric patients with neuropsychiatric systemic lupus erythematosus , 2009, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[57]  J. Todd,et al.  Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus , 2009, Genes and Immunity.

[58]  M. García-Carrasco,et al.  Risk factors of vertebral fractures in women with systemic lupus erythematosus , 2009, Clinical Rheumatology.

[59]  D. D'cruz.  Renal manifestations of the antiphospholipid syndrome , 2009, Current rheumatology reports.

[60]  L. Schanberg,et al.  Neurocognitive impairment in children and adolescents with systemic lupus erythematosus , 2009, Nature Clinical Practice Rheumatology.

[61]  M. Cerinic,et al.  Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study , 2009, Lupus.

[62]  J. Harley,et al.  Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. , 2009, Autoimmunity reviews.

[63]  E. Silverman,et al.  Autoantibodies in Pediatric Systemic Lupus Erythematosus: Ethnic Grouping, Cluster Analysis, and Clinical Correlations , 2009, The Journal of Rheumatology.

[64]  H. Kim,et al.  Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study , 2009, Lupus.

[65]  E. Silverman,et al.  B-Cell Depletion for Autoimmune Thrombocytopenia and Autoimmune Hemolytic Anemia in Pediatric Systemic Lupus Erythematosus , 2009, Pediatrics.

[66]  D. Myung,et al.  Lupus-associated pancreatitis complicated by pancreatic pseudocyst and central nervous system vasculitis , 2009, Lupus.

[67]  J. Bargman,et al.  Adipokines as novel biomarkers in paediatric systemic lupus erythematosus. , 2008, Rheumatology.

[68]  M. Khamashta,et al.  Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review , 2008, Annals of the rheumatic diseases.

[69]  Z. Farajzadegan,et al.  The protein–creatinine ratio in spot morning urine samples and 24-h urinary protein excretion in patients with systemic lupus erythematosus , 2009, Rheumatology International.

[70]  M. Abrahamowicz,et al.  Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. , 2008, Arthritis and rheumatism.

[71]  C. Zeng,et al.  Effects of mycophenolate mofetil for patients with crescentic lupus nephritis , 2008, Nephrology.

[72]  D. Seligson,et al.  MAGE-B2 Autoantibody: A New Biomarker for Pediatric Systemic Lupus Erythematosus , 2008, The Journal of Rheumatology.

[73]  T. Dörner,et al.  Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus , 2008, Lupus.

[74]  J. Bargman,et al.  Acute renal failure in paediatric systemic lupus erythematosus: treatment and outcome. , 2008, Rheumatology.

[75]  B. C. Kwan,et al.  Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis. , 2008, Rheumatology.

[76]  J. Staropoli,et al.  Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance , 2008, Transfusion.

[77]  E. Silverman,et al.  Pediatric Antiphospholipid Syndrome: Clinical and Immunologic Features of 121 Patients in an International Registry , 2008, Pediatrics.

[78]  D. Isenberg,et al.  Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus , 2008, Annals of the Rheumatic Diseases.

[79]  J. Sánchez-Guerrero,et al.  Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis , 2008, PloS one.

[80]  D. Isenberg,et al.  Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. , 2008, Rheumatology.

[81]  S. Özen,et al.  Musculoskeletal sonography in juvenile systemic lupus erythematosus , 2008, Pediatric Rheumatology Online Journal.

[82]  H. Nagaraja,et al.  Biomarkers of lupus nephritis determined by serial urine proteomics. , 2008, Kidney international.

[83]  D. Boumpas,et al.  Update on the management of lupus nephritis: let the treatment fit the patient , 2008, Nature Clinical Practice Rheumatology.

[84]  S. Kaneko,et al.  Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti‐erythropoietin autoantibodies , 2008, American journal of hematology.

[85]  T. Vassiliades,et al.  Acute Coronary Syndrome as a First Presentation of Systemic Lupus Erythematosus in a Teenager: Revascularization by Hybrid Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention: Case Report , 2008, Pediatric Cardiology.

[86]  C. Ponticelli,et al.  Cyclosporine (CsA) in lupus nephritis: assessing the evidence. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[87]  Bingqing Zhang,et al.  Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new‐onset systemic lupus erythematosus , 2008, Clinical and experimental immunology.

[88]  E. Treadwell,et al.  Childhood agricultural and adult occupational exposures to organic dusts in a population-based case–control study of systemic lupus erythematosus , 2008, Lupus.

[89]  H. Harigae,et al.  Reversible bone marrow dysplasia in patients with systemic lupus erythematosus. , 2008, Internal medicine.

[90]  B. Weinshenker,et al.  CNS aquaporin-4 autoimmunity in children , 2008, Neurology.

[91]  S. Aslanidis,et al.  Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway? , 2008, European journal of internal medicine.

[92]  S. Z,et al.  A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis , 2008, Lupus.

[93]  G. Ferraccioli,et al.  Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors , 2008, Lupus.

[94]  P. Lipsky,et al.  Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. , 2008, Arthritis and rheumatism.

[95]  E. Soriano,et al.  Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children , 2008, Lupus.

[96]  N. Mirza,et al.  Systemic lupus erythematosus, celiac disease and antiphospholipid antibody syndrome: a rare association , 2008, Rheumatology International.

[97]  R. Ghaleb,et al.  Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus , 2008, Clinical Rheumatology.

[98]  K. Hiromura,et al.  Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. , 2008, Rheumatology.

[99]  Q. Lu,et al.  DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients. , 2008, Autoimmunity reviews.

[100]  C. Sandborg,et al.  Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus , 2008, Nature Clinical Practice Rheumatology.

[101]  V. Pascual,et al.  The innate immune system in SLE: type I interferons and dendritic cells , 2008, Lupus.

[102]  G. Hamdy,et al.  CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. , 2008, Clinical immunology.

[103]  L. Salciccioli,et al.  Absence of Chlamydia pneumoniae and Signs of Atherosclerotic Cardiovascular Disease in Adolescents with Systemic Lupus Erythematosus , 2008, Pediatric Cardiology.

[104]  J. Anaya,et al.  Delayed lupus nephritis , 2008, Annals of the rheumatic diseases.

[105]  B. Hunt,et al.  Pediatric Antiphospholipid Antibodies and Antiphospholipid Syndrome , 2008, Seminars in thrombosis and hemostasis.

[106]  A. Goodman,et al.  Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome , 2008, Multiple sclerosis.

[107]  J. Rojas-Serrano,et al.  High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage , 2008, Lupus.

[108]  E. Silverman,et al.  Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. , 2008, The Journal of pediatrics.

[109]  Agustín R. Uribe,et al.  Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII) , 2008, Lupus.

[110]  G. Cooper,et al.  Recent Advances and Opportunities in Research on Lupus: Environmental Influences and Mechanisms of Disease , 2008, Environmental health perspectives.

[111]  S. Navarra,et al.  Clinical manifestations and clinical syndromes of Filipino patients with systemic lupus erythematosus , 2008, Modern rheumatology.

[112]  N. Shen,et al.  Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. , 2008, Arthritis and rheumatism.

[113]  A. Fattori,et al.  Systemic lupus erythematosus in patients with sickle cell disease , 2008, Clinical Rheumatology.

[114]  Y. Takasaki,et al.  Cavitary lung lesion in a patient with systemic lupus erythematosus: an unusual manifestation of cytomegalovirus pneumonitis , 2008, Modern rheumatology.

[115]  L. Peltonen,et al.  Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations , 2008, Journal of Medical Genetics.

[116]  E. Silverman,et al.  A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. , 2008, Arthritis and rheumatism.

[117]  D. Gladman,et al.  Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. , 2008, Arthritis and rheumatism.

[118]  L. Sailler.  Rituximab Off Label Use for Difficult-To-Treat Auto-Immune Diseases: Reappraisal of Benefits and Risks , 2008, Clinical reviews in allergy & immunology.

[119]  M. Klein-Gitelman,et al.  Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis , 2008, Pediatric Nephrology.

[120]  M. Santiago,et al.  Jaccoud Arthropathy in Systemic Lupus Erythematosus: Analysis of Clinical Characteristics and Review of the Literature , 2008, Medicine.

[121]  I. Durieu,et al.  Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies. , 2007, Rheumatology.

[122]  G. Zilleruelo,et al.  Rituximab therapy for juvenile-onset systemic lupus erythematosus , 2007, Pediatric Nephrology.

[123]  Raphael Zidovetzki,et al.  Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. , 2007, Arthritis and rheumatism.

[124]  C. Gordon,et al.  Ocular manifestations of systemic lupus erythematosus. , 2007, Rheumatology.

[125]  M. Peterson,et al.  Multicenter validation of a new quality of life measure in pediatric lupus. , 2007, Arthritis and rheumatism.

[126]  G. Alarcón,et al.  Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects. , 2007, Arthritis and rheumatism.

[127]  H. Nagaraja,et al.  Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. , 2007, Kidney international.

[128]  L. Benjilali,et al.  Pernicious anemia in a young man with systemic lupus erythematosus , 2007, Lupus.

[129]  Y. Kirino,et al.  Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. , 2007, Rheumatology.

[130]  A. Shabani,et al.  Clinical variability and characteristic autoantibody profile in primary C1q complement deficiency. , 2007, Rheumatology.

[131]  C. Kallenberg,et al.  Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism. , 2007, Arthritis and rheumatism.

[132]  M. Tonelli,et al.  Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[133]  D. Nochy,et al.  Antiphospholipid syndrome in systemic lupus erythematosus. , 2007, Journal of the American Society of Nephrology : JASN.

[134]  C. Kallenberg,et al.  Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus , 2007, Arthritis research & therapy.

[135]  J. Smolen,et al.  Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis , 2007, Annals of the rheumatic diseases.

[136]  L. Hiraki,et al.  Review: Measuring permanent damage in pediatric systemic lupus erythematosus , 2007 .

[137]  W. Poon,et al.  Recurrent Thrombotic Thrombocytopenic Purpura in a Young Boy With Systemic Lupus Erythematosus , 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[138]  V. Lilleby.  Review: Bone status in juvenile systemic lupus erythematosus , 2007 .

[139]  L. Criswell,et al.  Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. , 2007, Arthritis and rheumatism.

[140]  A. Martini,et al.  Antiphospholipid syndrome in pediatrics. , 2007, Rheumatic diseases clinics of North America.

[141]  T. Avčin,et al.  Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome , 2007, Lupus.

[142]  K. Leslie,et al.  Pulmonary pathology of the rheumatic diseases. , 2007, Seminars in respiratory and critical care medicine.

[143]  E. Silverman,et al.  Review: Neuropsychiatric involvement in pediatric systemic lupus erythematosus , 2007 .

[144]  Weiming Wang,et al.  Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[145]  G. Vaiopoulos,et al.  Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus , 2007, Lupus.

[146]  A. Martini,et al.  Systemic lupus erythematosus-like disease in a 6-year-old boy with prolidase deficiency , 2007, Journal of Inherited Metabolic Disease.

[147]  Y. Shoenfeld,et al.  Cardiac manifestations in antiphospholipid syndrome. , 2007, Autoimmunity reviews.

[148]  P. Liberalesso,et al.  Clinical, laboratory and neuroimage findings in juvenile systemic lupus erythematosus presenting involvement of the nervous system. , 2007, Arquivos de neuro-psiquiatria.

[149]  E. Silverman,et al.  Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. , 2007, Arthritis and rheumatism.

[150]  S. Makni,et al.  Hereditary Complement Deficiency and Lupus , 2007, Annals of the New York Academy of Sciences.

[151]  M. Vilardell‐Tarrés,et al.  DNA Methylation and Systemic Lupus Erythematosus , 2007, Annals of the New York Academy of Sciences.

[152]  M. Ward,et al.  Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. , 2007, Arthritis and rheumatism.

[153]  S. Muller,et al.  Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. , 2007, Arthritis and rheumatism.

[154]  M. Gershwin,et al.  Drug‐Induced Lupus , 2007, Annals of the New York Academy of Sciences.

[155]  L. Smeeth,et al.  Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. , 2007, Arthritis and rheumatism.

[156]  T. Yoshio,et al.  Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus , 2007, Arthritis research & therapy.

[157]  Y. Shoenfeld,et al.  Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus , 2007, Lupus.

[158]  E. Bonilla,et al.  Celiac disease in a patient with systemic lupus erythematosus: a case report and review of literature , 2007, Clinical Rheumatology.

[159]  E. Bonfá,et al.  Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus , 2007, Lupus.

[160]  J. Chapman,et al.  Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. , 2007, Seminars in arthritis and rheumatism.

[161]  C. Korkmaz,et al.  Myocardial infarction in young patients (≤35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature , 2007, Lupus.

[162]  E. Molden,et al.  Simvastatin‐Associated Rhabdomyolysis After Coadministration of Macrolide Antibiotics in Two Patients , 2007, Pharmacotherapy.

[163]  M. Verhaar,et al.  Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus , 2007, Annals of the rheumatic diseases.

[164]  R. Geddes.  Minocycline-induced lupus in adolescents: clinical implications for physical therapists. , 2007, The Journal of orthopaedic and sports physical therapy.

[165]  D. Mevorach,et al.  Lupus around the World , 2007 .

[166]  Jesús K. Estrada-Gil,et al.  Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus , 2007, European Journal of Human Genetics.

[167]  E. Donadi,et al.  Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations , 2007, Scandinavian journal of rheumatology.

[168]  N. Sebire,et al.  Clinicopathological correlations of paediatric lupus nephritis , 2007, Pediatric Nephrology.

[169]  M. Lam,et al.  A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade , 2007, Lupus.

[170]  N. Bianco,et al.  Opsonization by anti-dsDNA antibodies of apoptotic cells in systemic lupus erythematosus , 2007, Autoimmunity.

[171]  S. Revel-Vilk,et al.  Antiphospholipid syndrome and recurrent thrombosis in children. , 2006, Arthritis and rheumatism.

[172]  R. Moore,et al.  Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis , 2006, Arthritis research & therapy.

[173]  H. Anders,et al.  Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis. , 2006, Journal of the American Society of Nephrology : JASN.

[174]  V. Pascual,et al.  Systemic lupus erythematosus: all roads lead to type I interferons. , 2006, Current opinion in immunology.

[175]  E. Karlson,et al.  Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. , 2006, Arthritis and rheumatism.

[176]  C. Cooper,et al.  Early environmental exposure and the development of lupus , 2006, Lupus.

[177]  S. Vasoo.  Drug-induced lupus: an update , 2006, Lupus.

[178]  C. Parks,et al.  Occupational exposures and risk of systemic lupus erythematosus: a review of the evidence and exposure assessment methods in population-and clinic-based studies , 2006, Lupus.

[179]  L. Orozco,et al.  Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population , 2006, Genes and Immunity.

[180]  V. Pascual,et al.  Persistent expression of autoantibodies in SLE patients in remission , 2006, The Journal of experimental medicine.

[181]  B. Chiang,et al.  Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study , 2006, Lupus.

[182]  D. Armstrong,et al.  Accelerated apoptosis in SLE neutrophils cultured with anti-dsDNA antibody isolated from SLE patient serum: a pilot study , 2006, Rheumatology International.

[183]  D. Kono,et al.  Genetics of SLE in mice , 2006, Springer Seminars in Immunopathology.

[184]  A. Martini,et al.  A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[185]  R. H. Scofield,et al.  Autoantibody Determination in the Diagnosis of Systemic Lupus Erythematosus , 2006, Scandinavian journal of immunology.

[186]  D. Witte,et al.  Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[187]  J. Piette,et al.  Abdominal manifestations in childhood-onset systemic lupus erythematosus , 2006, Annals of the rheumatic diseases.

[188]  S. Giannouli,et al.  Suspects in the tale of lupus‐associated thrombocytopenia , 2006, Clinical and experimental immunology.

[189]  R. Cron,et al.  Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[190]  C. Kallenberg,et al.  Quantitation of Autoantibodies in Systemic Autoimmune Diseases: Clinically Useful? , 2006, Lupus.

[191]  Y. Ikeda,et al.  Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. , 2006, Rheumatology.

[192]  R. Pandey,et al.  Autonomic dysfunction in systemic lupus erythematosus , 2006, Rheumatology International.

[193]  M. Kiss,et al.  Increased Fas and Bcl-2 Expression on Peripheral Blood T and B Lymphocytes from Juvenile-Onset Systemic Lupus Erythematosus, but not from Juvenile Rheumatoid Arthritis and Juvenile Dermatomyositis , 2006, Clinical & developmental immunology.

[194]  M. Lam,et al.  Quality of life comparison between corticosteroidand-mycofenolate mofetil and corticosteroidand-oral cyclophosphamide in the treatment of severe lupus nephritis , 2006, Lupus.

[195]  E. Haddad,et al.  Rituximab therapy for childhood-onset systemic lupus erythematosus. , 2006, The Journal of pediatrics.

[196]  C. Mohan,et al.  What do mouse models teach us about human SLE? , 2006, Clinical immunology.

[197]  J. Piette,et al.  Characteristics and Long-Term Outcome of 15 Episodes of Systemic Lupus Erythematosus-Associated Hemophagocytic Syndrome , 2006, Medicine.

[198]  R. Schneider,et al.  Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. , 2006, The Journal of pediatrics.

[199]  D. Liu,et al.  Non-myeloablative allogeneic stem cell transplant in a patient with refractory systemic lupus erythematosus , 2006, Bone Marrow Transplantation.

[200]  C. Chow,et al.  Lupus nephritis in Chinese children – a territory-wide cohort study in Hong Kong , 2006, Pediatric Nephrology.

[201]  H. Sugiyama,et al.  Good response of membranous lupus nephritis to tacrolimus. , 2006, Clinical nephrology.

[202]  S. Marks,et al.  Successful outcomes with rituximab therapy for refractory childhood systemic lupus erythematosus , 2006, Pediatric Nephrology.

[203]  E. Matteson,et al.  Lupus arthropathy: a case series of patients with rhupus , 2006, Clinical Rheumatology.

[204]  Sang-Do Lee,et al.  Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension , 2006, Clinical Rheumatology.

[205]  N. Heshmat,et al.  Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus , 2006, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[206]  Wang Lan-lan,et al.  Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. , 2006, Cellular immunology.

[207]  P. Ferguson,et al.  Shrinking Lung Syndrome in a 14‐Year‐Old Boy with Systemic Lupus Erythematosus , 2006, Pediatric pulmonology.

[208]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[209]  M. Kawai,et al.  Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism. , 2006, Rheumatology.

[210]  Chen-Kang Chang,et al.  A positive correlation between homocysteine and brachial–ankle pulse wave velocity in patients with systemic lupus erythematosus , 2006, Clinical Rheumatology.

[211]  H. Kimura,et al.  Fatal varicella infection in a girl with systemic lupus erythematosus after oral acyclovir prophylaxis , 2006, European Journal of Pediatrics.

[212]  K. Eguchi,et al.  Emergence of Epstein-Barr virus-associated haemophagocytic syndrome upon treatment of systemic lupus erythematosus , 2006, Lupus.

[213]  T. Miyamoto,et al.  Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis , 2006, American journal of hematology.

[214]  A. Aleem,et al.  Thrombotic Thrombocytopenic Purpura Associated with Systemic Lupus Erythematosus , 2006, Acta Haematologica.

[215]  H. Misawa,et al.  Steroid-induced psychosis treated with valproic acid and risperidone in a patient with systemic lupus erythematosus. , 2005, Primary care companion to the Journal of clinical psychiatry.

[216]  F. Ingegnoli,et al.  Evaluation of Nailfold Videocapillaroscopic Abnormalities in Patients With Systemic Lupus Erythematosus , 2005, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[217]  Mimi Y. Kim,et al.  Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. , 2005, The New England journal of medicine.

[218]  H. Chang.  Successful Treatment of Refractory Thrombocytopenia with Mycophenolate Mofetil in a Patient with Systemic Lupus Erythematosus , 2005, Journal of Korean medical science.

[219]  H. Bagavant,et al.  New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells , 2005, Current opinion in rheumatology.

[220]  M. Haugen,et al.  Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[221]  D A Isenberg,et al.  Development and initial validation of an updated version of the British Isles Lupus Assessment Group ’ s disease activity index for patients with systemic lupus erythematosus , 2005 .

[222]  Heike Anders.  A Toll for lupus , 2005, Lupus.

[223]  E. von Scheven,et al.  Association between β2-glycoprotein I gene polymorphisms and pediatric SLE and antiphospholipid antibodies , 2005 .

[224]  T. Cheng,et al.  Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin A: a case report , 2005, Lupus.

[225]  G. Espinosa,et al.  Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients , 2005, Annals of the rheumatic diseases.

[226]  T. Horiuchi,et al.  Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI , 2005, Lupus.

[227]  M. Peterson,et al.  Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. , 2005, Arthritis and rheumatism.

[228]  E. Haddad,et al.  Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. , 2005, The Journal of pediatrics.

[229]  A. Zlotnik,et al.  Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. , 2005, Arthritis and rheumatism.

[230]  R. Jonsson,et al.  Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors , 2005, European journal of neurology.

[231]  P. Mathieson,et al.  Mycophenolate Mofetil for Remission Induction in Severe Lupus Nephritis , 2005, Nephron Clinical Practice.

[232]  R. Rubin,et al.  Drug-induced lupus. , 2005, Toxicology.

[233]  K. Lai,et al.  Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine , 2005, Lupus.

[234]  T. Chan,et al.  Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. , 2005, Journal of the American Society of Nephrology : JASN.

[235]  L. Zimmerhackl,et al.  Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression , 2005, Pediatric Nephrology.

[236]  V. Pascual,et al.  Defective B cell tolerance checkpoints in systemic lupus erythematosus , 2005, The Journal of experimental medicine.

[237]  Y. Mori,et al.  Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis , 2005, Clinical and Experimental Nephrology.

[238]  H. Zinger,et al.  Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus , 2005, Annals of the rheumatic diseases.

[239]  J. Esdaile,et al.  Methotrexate in systemic lupus erythematosus , 2005, Lupus.

[240]  R. Caporali,et al.  Autoantibodies to heterogeneous nuclear ribonucleoproteins , 2005, Autoimmunity.

[241]  S. Bombardieri,et al.  Anti-Sm and anti-RNP antibodies , 2005, Autoimmunity.

[242]  M. Beresford,et al.  Cardio-pulmonary involvement in juvenile systemic lupus erythematosus , 2005, Lupus.

[243]  L. Caponi,et al.  Anti-ribosomal P protein antibodies , 2005, Autoimmunity.

[244]  F. Franceschini,et al.  Anti-Ro/SSA and La/SSB antibodies , 2005, Autoimmunity.

[245]  P Dastidar,et al.  Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population‐based study , 2005, Scandinavian journal of rheumatology.

[246]  Y. Shoenfeld,et al.  Infections and SLE , 2005, Autoimmunity.

[247]  F. Cendes,et al.  Epileptic seizures in systemic lupus erythematosus , 2004, Neurology.

[248]  B. Brenner,et al.  Why is proteinuria an ominous biomarker of progressive kidney disease? , 2004, Kidney international. Supplement.

[249]  M. Oshimura,et al.  Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[250]  V. Deleo,et al.  Photosensitivity in lupus erythematosus , 2004, Photodermatology, photoimmunology & photomedicine.

[251]  Y. Shoenfeld,et al.  Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. , 2004, Seminars in arthritis and rheumatism.

[252]  F. Houssiau.  Management of lupus nephritis: an update. , 2004, Journal of the American Society of Nephrology : JASN.

[253]  M. Ward.  Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. , 2004, Journal of women's health.

[254]  F. Haramburu,et al.  Tumour necrosis factor α antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery , 2004, Annals of the rheumatic diseases.

[255]  Hiroshi Watanabe,et al.  Antibodies to triosephosphate isomerase in patients with neuropsychiatric lupus. , 2004, Biochemical and biophysical research communications.

[256]  P. Houtman,et al.  Peripheral neuropathy--a rare complication of paediatric systemic lupus erythematosus. , 2004, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[257]  B. Balkaran,et al.  Systemic lupus erythematosus in Trinidadian children , 2004, Annals of tropical paediatrics.

[258]  P. Woo,et al.  The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. , 2004, Rheumatology.

[259]  Kristin G Ardlie,et al.  Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. , 2004, American journal of human genetics.

[260]  A. Tzioufas,et al.  Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide , 2004, Lupus.

[261]  M. Ward.  Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels. , 2004, Arthritis and rheumatism.

[262]  C. Lau,et al.  Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. , 2004, Arthritis and rheumatism.

[263]  L. Morel.  Mouse Models of Human Autoimmune Diseases: Essential Tools That Require the Proper Controls , 2004, PLoS biology.

[264]  A. Malaviya,et al.  Systemic lupus erythematosus in Kuwaiti children: organ system involvement and serological findings , 2004, Lupus.

[265]  S. Al‐Mayouf,et al.  Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus , 2004, Clinical Rheumatology.

[266]  E. Matteson,et al.  Lupus arthropathy: historical evolution from deforming arthritis to rhupus , 2004, Clinical Rheumatology.

[267]  K. Berend,et al.  Results of free vascularized fibular grafting for femoral head osteonecrosis in patients with systemic lupus erythematosus. , 2004, The Orthopedic clinics of North America.

[268]  D. Gladman,et al.  Pulmonary hypertension in systemic lupus , 2004, Lupus.

[269]  S. Makni,et al.  Systemic lupus erythematosus with celiac disease: a report of five cases. , 2004, Joint, bone, spine : revue du rhumatisme.

[270]  M. Malloy,et al.  Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[271]  A. Reiff,et al.  Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. , 2004, Arthritis and rheumatism.

[272]  H. Chng,et al.  Pulmonary hemorrhage in systemic lupus erythematosus. , 2004, Seminars in arthritis and rheumatism.

[273]  D. Jayne.  Stem cell transplantation in systemic lupus erythematosus. , 2004, Best practice & research. Clinical haematology.

[274]  H. Goldschmidt,et al.  Malignancy in renal transplantation. , 2004, Journal of the American Society of Nephrology : JASN.

[275]  L. Rönnblom,et al.  Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. , 2004, Arthritis and rheumatism.

[276]  S. Godfrey.  Pulmonary hemorrhage/hemoptysis in children , 2004, Pediatric pulmonology.

[277]  D. Isenberg,et al.  Thrombotic risk in patients submitted to splenectomy for systemic lupus erythematosus and antiphospholipid antibody syndrome-related thrombocytopenia. , 2004, European journal of internal medicine.

[278]  P. Goadsby,et al.  A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. , 2004, Brain : a journal of neurology.

[279]  E. Tan,et al.  Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[280]  M. Peterson,et al.  Quality of life in paediatric lupus , 2004, Lupus.

[281]  D. Roth,et al.  Sequential therapies for proliferative lupus nephritis. , 2004, The New England journal of medicine.

[282]  G. Sturfelt,et al.  Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus − an additional mechanism to increased autoantigen load? , 2004, Clinical and experimental immunology.

[283]  T. Lehtimäki,et al.  Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. , 2004, Arthritis and rheumatism.

[284]  J. O'day,et al.  Review of severe vaso‐occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment , 2004, Clinical & experimental ophthalmology.

[285]  A. Garcia-Gonzalez,et al.  Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus , 2004, Lupus.

[286]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[287]  R. Atkins,et al.  Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[288]  Toru Watanabe,et al.  Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis , 2004, Pediatric Nephrology.

[289]  E. Silverman,et al.  Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus. , 2003, The Journal of pediatrics.

[290]  C. Gutiérrez,et al.  Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features , 2003, Lupus.

[291]  M. Kiss,et al.  Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus , 2003, Lupus.

[292]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[293]  P. Leszczyński,et al.  Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies , 2003, Clinical Rheumatology.

[294]  C. Lau,et al.  Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. , 2003, Arthritis and rheumatism.

[295]  F. Lluís,et al.  Chronic pancreatitis associated with systemic lupus erythematosus in a young girl. , 2003, Pancreas.

[296]  D. Hébert,et al.  Thromboembolism in paediatric lupus patients , 2003, Lupus.

[297]  V. D’Agati,et al.  Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[298]  V. Pascual,et al.  The central role of dendritic cells and interferon-&agr; in SLE , 2003 .

[299]  G. Hughes,et al.  Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients , 2003, Medicine.

[300]  C. Lau,et al.  Lupus in Hong Kong Chinese , 2003, Lupus.

[301]  M. Meurer.  Childhood Discoid Lupus erythematosus and Antimalarials , 2003, Dermatology.

[302]  J. Thumboo,et al.  Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil , 2003, Lupus.

[303]  A. Johnson,et al.  Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage , 2003, Lupus.

[304]  T. Hagemann,et al.  Promethazine Treatment of Steroid-Induced Psychosis in a Child , 2003, The Annals of pharmacotherapy.

[305]  C. Bombardier,et al.  European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus. , 2003, Arthritis and rheumatism.

[306]  B. McCrindle,et al.  The relative roles of transthoracic compared with transesophageal echocardiography in children with suspected infective endocarditis. , 2003, Journal of the American College of Cardiology.

[307]  T. Koike,et al.  Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement. , 2003, Rheumatology.

[308]  C. Fiehn,et al.  Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment , 2003, Annals of the rheumatic diseases.

[309]  Yung-Yee Chang,et al.  The Prevalence of Protein C, Protein S, and Antithrombin III Deficiency in non-APS/SLE Chinese Adults with Noncardiac Cerebral Ischemia , 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[310]  C. Aebi,et al.  Systemic lupus erythematosus initially presenting as idiopathic juvenile arthritis with positive antinuclear antibodies , 2003, Acta paediatrica.

[311]  A. Fogo,et al.  Recurrent lupus nephritis in renal transplant recipients revisited: It is not rare1 , 2003, Transplantation.

[312]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[313]  P. Cohen,et al.  Animal models for SLE. , 2003, Current protocols in immunology.

[314]  F. Boehlen,et al.  Severe thrombocytopenic purpura due to rubella infection in a patient with systemic lupus erythematosus , 2003, Lupus.

[315]  L. Espinoza,et al.  Acute abdomen due to spontaneous organ rupture in systemic lupus erythematosus. , 2003, The American journal of medicine.

[316]  D. Gipson,et al.  Renal transplantation in children with lupus nephritis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[317]  C. Feighery,et al.  Anti-transglutaminase antibodies and the serological diagnosis of coeliac disease , 2003, British journal of biomedical science.

[318]  P. Rieu,et al.  SLE and idiopathic nephrotic syndrome: coincidence or not? , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[319]  V. Pascual,et al.  Blood dendritic cells and DC-poietins in systemic lupus erythematosus. , 2002, Human immunology.

[320]  B. Cohen,et al.  Hypocomplementemic urticarial vasculitis: report of a 12-year-old girl with systemic lupus erythematosus. , 2002, Journal of the American Academy of Dermatology.

[321]  S. Rockson,et al.  Myocarditis in systemic lupus erythematosus. , 2002, The American journal of medicine.

[322]  V. Pascual,et al.  The interplay of dendritic cell subsets in systemic lupus erythematosus , 2002, Immunology and cell biology.

[323]  Hans L Hillege,et al.  Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.

[324]  K. Pavithran,et al.  Aplastic anemia complicating systemic lupus erythematosus – report of a case and review of the literature , 2002, Rheumatology International.

[325]  Glinda S Cooper,et al.  Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. , 2002, Journal of clinical epidemiology.

[326]  D. Glidden,et al.  Anti-β2-Glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome , 2002 .

[327]  I. Kobayashi,et al.  Central nervous system manifestations after steroid pulse therapy in systemic lupus erythematosus , 2002, European Journal of Pediatrics.

[328]  M. Vilar,et al.  Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil) , 2002, Lupus.

[329]  Y. Ikeda,et al.  Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia. , 2002, Arthritis and rheumatism.

[330]  L. Czirják,et al.  Self limiting lupus-like symptoms in patients with parvovirus B19 infection , 2002, Annals of the rheumatic diseases.

[331]  H. Blau,et al.  Peripheral neuropathy in pediatric systemic lupus erythematosus. , 2002, Pediatric neurology.

[332]  A. Gorshtein,et al.  Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort{ , 2002, Lupus.

[333]  F. Ciccia,et al.  Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level , 2002, Annals of the rheumatic diseases.

[334]  E. Wakeland,et al.  Susceptibility genes in the pathogenesis of murine lupus , 2002, Arthritis research.

[335]  J. Granados,et al.  Clinical and immunogenetic characterization of Mexican patients with ‘Rhupus’ , 2002, Lupus.

[336]  A. Köşlü,et al.  Cockayne syndrome with generalized discoid lupus erythematosus‐like lesions , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[337]  A. Bolger,et al.  Unique features of infective endocarditis in childhood. , 2002, Circulation.

[338]  G. Gronseth,et al.  Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions , 2002, Neurology.

[339]  G. Illei,et al.  Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. , 2002, Arthritis and rheumatism.

[340]  G. Hughes,et al.  Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. , 2002, Seminars in arthritis and rheumatism.

[341]  G. Schett,et al.  Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosus , 2002, Lupus.

[342]  A. Ramanan,et al.  Acute lethal pancreatitis in childhood systemic lupus erythematosus. , 2002, Rheumatology.

[343]  J. Varni,et al.  The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. , 2002, Arthritis and rheumatism.

[344]  C. Bombardier,et al.  Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. , 2002, Arthritis and rheumatism.

[345]  A. Wozniacka,et al.  Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit , 2002, Lupus.

[346]  C. Edwards.  Lupus in Singapore , 2001, Lupus.

[347]  A. Auvinen,et al.  Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. , 2001, Arthritis and rheumatism.

[348]  J. Axford,et al.  Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus , 2001, British journal of haematology.

[349]  M. McClain,et al.  The role of Epstein-Barr virus in systemic lupus erythematosus. , 2001, Frontiers in bioscience : a journal and virtual library.

[350]  T. Ruzicka,et al.  Phototesting in lupus erythematosus: a 15-year experience. , 2001, Journal of the American Academy of Dermatology.

[351]  M. Segasothy,et al.  Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study , 2001, Lupus.

[352]  J. Hunyadi,et al.  UVB light and 17-β-estradiol have different effects on the mRNA expression of Ro/SSA and La/SSB autoantigens in HaCaT cells , 2001, Archives of Dermatological Research.

[353]  K. Malizos,et al.  Treatment of Avascular Necrosis of the Femoral Head With Vascularized Fibular Transplant , 2001, Clinical orthopaedics and related research.

[354]  J. Harley,et al.  Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. , 2001, Arthritis and rheumatism.

[355]  J. Miller,et al.  Case series: neuropsychiatric symptoms with pediatric systemic lupus erythematosus. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[356]  B. Griffiths,et al.  The treatment of lupus with cyclosporin A , 2001, Lupus.

[357]  A. Nayır,et al.  Lupus Nephritis in Children: Prognostic Significance of Clinicopathological Findings , 2001, Nephron.

[358]  M. Seear,et al.  Echocardiography and pulmonary function testing in childhood onset systemic lupus erythematosus , 2001, Lupus.

[359]  V. Miller,et al.  Neurologic Symptoms in Children With Systemic Lupus Erythematosus , 2000, Journal of child neurology.

[360]  R. Erickson,et al.  Variable presentation of Rothmund-Thomson syndrome. , 2000, American journal of medical genetics.

[361]  M. Ward,et al.  The rating scale preference measure as an evaluative measure in systemic lupus erythematosus , 2000, Lupus.

[362]  B. Fessler,et al.  Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. , 2000, Chest.

[363]  P. Gaburri,et al.  Fatal evolution of systemic lupus erythematosus associated with Crohn's disease. , 2000, Arquivos de gastroenterologia.

[364]  G. Burmester,et al.  Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. , 2000, Arthritis and rheumatism.

[365]  J. Jenkins,et al.  A fatal case of pancreatic panniculitis presenting in a young patient with systemic lupus , 2000, Journal of cutaneous pathology.

[366]  M. Piga,et al.  Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations , 2000, Lupus.

[367]  Y. Tada,et al.  Retinal disease in patients with systemic lupus erythematosus , 2000, Annals of the rheumatic diseases.

[368]  S. Bombardieri,et al.  The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus , 2000, Lupus.

[369]  F. Falaschi,et al.  Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. , 2000, Arthritis and rheumatism.

[370]  D. Wallace,et al.  Cyclosporine for lupus membranous nephritis:experience with ten patients and review of the literature , 2000, Lupus.

[371]  N. Rao,et al.  Occlusive retinal vasculitis associated with systemic lupus erythematosus. , 2000, Archives of ophthalmology.

[372]  C. Lau,et al.  A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. , 2000, Rheumatology.

[373]  A. M. Johnston,et al.  Lupus anticoagulant in a patient with parvovirus B19 infection. , 2000, Clinical and laboratory haematology.

[374]  H. K. Kim,et al.  Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus. , 2000, Arthritis and rheumatism.

[375]  J. Ioannidis,et al.  Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin , 2000, Annals of the rheumatic diseases.

[376]  W. Sewell,et al.  Drug-Induced Aseptic Meningitis , 2000, Drug safety.

[377]  J. Ioannidis,et al.  Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. , 2000, The American journal of medicine.

[378]  M. Keane,et al.  Pleuropulmonary manifestations of systemic lupus erythematosus , 2000, Rheumatic diseases clinics of North America.

[379]  L. Fossati-Jimack,et al.  Lessons from BXSB and Related Mouse Models , 2000, International reviews of immunology.

[380]  A. Widell,et al.  No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19 , 2000, Annals of the rheumatic diseases.

[381]  J. Goo,et al.  Pulmonary tuberculosis in patients with systematic lupus erythematosus. , 1999, AJR. American journal of roentgenology.

[382]  E. Silverman,et al.  Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. , 1999, Arthritis and rheumatism.

[383]  G. Vaiopoulos,et al.  Sickle cell/β0-Thalassemia and systemic lupus erythematosus , 1999 .

[384]  V. Holers.  Complement deficiency states, disease susceptibility, and infection risk in systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[385]  A. Gabrielli,et al.  Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus. , 1999, Clinical immunology.

[386]  S. Buys,et al.  The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations. , 1999, Arthritis and rheumatism.

[387]  S. Berrak,et al.  Sagittal sinus thrombosis associated with thrombocytopenia: a report of two patients. , 1999, Pediatric neurology.

[388]  J. Harley,et al.  Epstein-Barr virus infection may be an environmental risk factor for systemic lupus erythematosus in children and teenagers. , 1999, Arthritis and rheumatism.

[389]  C. Bombardier,et al.  Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[390]  S. Karpatkin,et al.  Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis‐cirrhosis, and HIV‐1 infection by platelet and serum immunological measurements , 1999, British journal of haematology.

[391]  S. Kiechl,et al.  Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood. , 1999, Neuropediatrics.

[392]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[393]  S. Trapani,et al.  Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. , 1999, Seminars in arthritis and rheumatism.

[394]  T. Moore,et al.  Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. , 1999, Seminars in arthritis and rheumatism.

[395]  D. Wallace.  Apheresis for lupus erythematosus , 1999, Lupus.

[396]  Ferguson,et al.  Photosensitivity and the Rothmund–Thomson syndrome , 1998, The British journal of dermatology.

[397]  J. Bijlsma,et al.  Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus , 1998, Annals of the rheumatic diseases.

[398]  C. Lau,et al.  Risk factors for avascular bone necrosis in systemic lupus erythematosus. , 1998, British journal of rheumatology.

[399]  M. Reichlin,et al.  The association between anti-ribosomal P antibodies and active nephritis in systemic lupus erythematosus. , 1998, Clinical immunology and immunopathology.

[400]  B. Maldague,et al.  Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodies. , 1998, British journal of rheumatology.

[401]  S. Jabłońska,et al.  Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. , 1998, Journal of the American Academy of Dermatology.

[402]  M. Abrahamowicz,et al.  Impact of disease activity and cumulative damage on the health of lupus patients , 1998, Lupus.

[403]  E. Tsakonas,et al.  A Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus Erythematosus , 1998 .

[404]  L. Yang,et al.  Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria. , 1998, British journal of rheumatology.

[405]  J. Harley,et al.  An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. , 1997, The Journal of clinical investigation.

[406]  J. Robyn,et al.  Systemic lupus erythematosus: a risk factor for pneumonia caused by Legionella micdadei? , 1997, Archives of internal medicine.

[407]  A. Tzioufas,et al.  Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus: correlation with anemia. , 1997, Arthritis and rheumatism.

[408]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[409]  M. Lewis,et al.  Prolidase deficiency and systemic lupus erythematosus , 1997, Archives of disease in childhood.

[410]  D. Gladman,et al.  The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[411]  M. Okuni,et al.  A nationwide surveillance study of rheumatic diseases among Japanese children , 1997, Acta paediatrica Japonica : Overseas edition.

[412]  A. Gedalia,et al.  Anti-Ro/SS-A and anti-La/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus , 1997, Annals of the rheumatic diseases.

[413]  V. Barak,et al.  Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus. , 1997, British journal of rheumatology.

[414]  I. Rosenberg,et al.  Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus , 1996, The Lancet.

[415]  Y. Shoenfeld,et al.  Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves , 1996, Lupus.

[416]  Y. Shoenfeld,et al.  Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. , 1996, Circulation.

[417]  K. Elkon,et al.  Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. , 1996, Arthritis and rheumatism.

[418]  A. Flanders,et al.  MRI and angiographic diagnosis of lupus cerebral vasculitis , 1996, Neuroradiology.

[419]  Y. M. Yang,et al.  Systemic lupus erythematosus in a child with sickle cell disease. , 1995, Southern medical journal.

[420]  Youngki Kim,et al.  Neurologic characteristics of childhood lupus erythematosus. , 1995, Pediatric neurology.

[421]  E. Silverman,et al.  Neurologic manifestations of pediatric systemic lupus erythematosus. , 1995, Pediatric neurology.

[422]  A. Buchman,et al.  Crohn's disease masquerading as systemic lupus erythematosus. , 1995, Southern medical journal.

[423]  C. Kwoh,et al.  Incidence of systemic lupus erythematosus. Race and gender differences. , 1995, Arthritis and rheumatism.

[424]  D. Isenberg,et al.  Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. , 1995, British journal of rheumatology.

[425]  M. Abe,et al.  Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE) , 1995, Clinical and experimental immunology.

[426]  L. Tucker,et al.  Neuropsychological assessment of children and adolescents with systemic lupus erythematosus , 1995, Lupus.

[427]  R. Schneider,et al.  Cerebral vein thrombosis in childhood systemic lupus erythematosus. , 1995, The Journal of pediatrics.

[428]  J. Denburg,et al.  Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. , 1995, The American journal of medicine.

[429]  S. Aysun,et al.  Association of antiphospholipid antibodies with systemic lupus erythematosus in a child presenting with chorea: A case report , 1994, European Journal of Pediatrics.

[430]  B. Richardson,et al.  Role of T Cell DNA Methylation in Lupus Syndromes , 1994, Lupus.

[431]  T. Moore,et al.  Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus , 1994 .

[432]  N. Pelc,et al.  Erythropoietic protoporphyria and lupus erythematosus: case report and review of the literature. , 1994, Archives of dermatology.

[433]  R. Jorde,et al.  Autonomic Function in Systemic Lupus Erythematosus , 1994, Lupus.

[434]  E. Silverman,et al.  Hypoprothrombinemia in childhood systemic lupus erythematosus. , 1994, Seminars in arthritis and rheumatism.

[435]  R. Madhavan,et al.  Childhood systemic lupus erythematosus in South India , 1994, Indian journal of pediatrics.

[436]  J. Denburg,et al.  Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus. Relationship of lymphocyte antibody specificities to clinical disease. , 1994, Arthritis and rheumatism.

[437]  L. Ketonen,et al.  Co‐twin control study on cerebral manifestations of systemic lupus erythematosus , 1993, Acta neurologica Scandinavica.

[438]  D. Isenberg,et al.  Haematological manifestations of systemic lupus erythematosus. , 1993, Blood reviews.

[439]  S. Bombardieri,et al.  Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein‐Barr virus‐encoded nuclear antigen EBNA I , 1993, European journal of immunology.

[440]  J. Fisk,et al.  COGNITIVE IMPAIRMENT AND AUTOANTLBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1993 .

[441]  J. Reveille,et al.  Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. , 1993, Arthritis and rheumatism.

[442]  M. Doherty,et al.  The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. , 1993, British journal of rheumatology.

[443]  Y. Niho,et al.  High levels of antibody to varicella-zoster virus in systemic lupus erythematosus. , 1992, The Journal of infectious diseases.

[444]  A. Alonso,et al.  Systemic lupus erythematosus: A case report with unusual manifestations and favourable outcome after plasmapheresis , 1992, European Journal of Pediatrics.

[445]  M. Newkirk,et al.  Effect of ultraviolet irradiation on selected host cell proteins including Ro/SS-A and Epstein-Barr virus in cultured lymphoblastoid cell lines. , 1992, Journal of autoimmunity.

[446]  H. Spiera,et al.  Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein , 1992, The Journal of experimental medicine.

[447]  M. Walport,et al.  Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus. , 1992, British journal of rheumatology.

[448]  A. Cope,et al.  Possible induction of systemic lupus erythematosus by human parvovirus. , 1992, Annals of the rheumatic diseases.

[449]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[450]  E. Lewis,et al.  A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. , 1992, The New England journal of medicine.

[451]  W. Cossermelli,et al.  Antiganglioside Antibodies in Patients with Neuropsychiatric Systemic Lupus Erythematosus , 1992, Lupus.

[452]  T. Mack,et al.  A revised estimate of twin concordance in systemic lupus erythematosus. , 1992, Arthritis and rheumatism.

[453]  D. Vaux,et al.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[454]  A. Drosos,et al.  Clinical and serological spectrum of systemic lupus erythematosus in greek children , 1991, Clinical Rheumatology.

[455]  E. Silverman,et al.  Presence of thyroid abnormalities in children with systemic lupus erythematosus. , 1991, The Journal of pediatrics.

[456]  D. Isenberg,et al.  Total and free protein S in systemic lupus erythematosus. , 1990, Thrombosis research.

[457]  M. Khamashta,et al.  Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus , 1990, The Lancet.

[458]  A. Drosos,et al.  Subacute cutaneous lupus-erythematosus in childhood , 1989, Clinical Rheumatology.

[459]  D. Isenberg,et al.  Elevation of the levels of SmB, B' and D proteins but not that of the La (SS-B) antigen during HSV infections. , 1989, Journal of autoimmunity.

[460]  M. Liang,et al.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.

[461]  L. Costallat,et al.  Neuropsychiatric manifestations of systemic lupus erythematosus: The value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies , 1989, Clinical Rheumatology.

[462]  E. Passarge,et al.  Bloom's Syndrome. XII. Report from the Registry for 1987 , 1989, Clinical genetics.

[463]  G. E. Gresham,et al.  The efficacy of antimalarials in systemic lupus erythematosus. , 1988, The Journal of rheumatology.

[464]  J. Soler‐Soler,et al.  Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. , 1988, The New England journal of medicine.

[465]  J. Denburg,et al.  Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus , 1988, Brain, Behavior, and Immunity.

[466]  K. Sirnes,et al.  Chorea and lupus anticoagulant: a case report , 1988, Acta neurologica Scandinavica.

[467]  P. Turski,et al.  Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging. , 1988, Arthritis and rheumatism.

[468]  W. Coon.  Splenectomy for cytopenias associated with systemic lupus erythematosus. , 1988, American journal of surgery.

[469]  D. Isenberg,et al.  Acute pancreatitis in systemic lupus erythematosus: report of a case unrelated to drug therapy. , 1988, Annals of the rheumatic diseases.

[470]  J. Pincott,et al.  Dominantly inherited glomerulonephritis and an unusual skin disease. , 1987, Archives of disease in childhood.

[471]  M. Petri,et al.  Fatal Infections in Systemic Lupus Erythematosus: The Role of Opportunistic Organisms , 1987, Medicine.

[472]  A. Martini,et al.  Systemic lupus erythematosus with Jaccoud's arthropathy mimicking juvenile rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[473]  N. Brot,et al.  Association between lupus psychosis and anti-ribosomal P protein antibodies. , 1987, The New England journal of medicine.

[474]  K. Luke,et al.  Systemic lupus erythematosus and sickle hemoglobinopathies: A report of two cases and review of the literature , 1987, American journal of hematology.

[475]  J. Denburg,et al.  Neuronal antibodies and cognitive function in systemic lupus erythematosus , 1987, Neurology.

[476]  A. Kalla,et al.  Early treatment of avascular necrosis in systemic lupus erythematosus. , 1986, Annals of the rheumatic diseases.

[477]  Danon Yl,et al.  Autoantibodies to neuroblastoma cell surface antigens in neuropsychiatric lupus. , 1986 .

[478]  R. Siegel,et al.  Cardiovascular manifestations of systemic lupus erythematosus. , 1985, American heart journal.

[479]  J. Denburg,et al.  Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. , 1985, Arthritis and rheumatism.

[480]  D. Felson,et al.  Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis. , 1984, The New England journal of medicine.

[481]  E. Mooney.  Complement factor 6 deficiency associated with lupus. , 1984, Journal of the American Academy of Dermatology.

[482]  L. Cohn,et al.  Aortic and mitral insufficiency complicating fulminant systemic lupus erythematosus. , 1984, Chest.

[483]  P. White,et al.  Psychiatric Manifestations of Systemic Lupus Erythematosus in Children and Adolescents , 1984, Clinical pediatrics.

[484]  E. Mantzouranis,et al.  Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients. , 1983, Clinical immunology and immunopathology.

[485]  N. Penneys,et al.  Childhood systemic lupus erythematosus. Association with pancreatitis, subcutaneous fat necrosis, and calcinosis cutis. , 1983 .

[486]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[487]  B. Athreya,et al.  Central nervous system involvement in childhood systemic lupus erythematosus. , 1981, Arthritis and rheumatism.

[488]  G. Hughes,et al.  Systemic lupus erythematosus in childhood. , 1981, Annals of the rheumatic diseases.

[489]  C. Pui,et al.  Evans syndrome in childhood. , 1980, The Journal of pediatrics.

[490]  B. Bresnihan,et al.  The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms. , 1979, Annals of the rheumatic diseases.

[491]  A. Saxon,et al.  Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis. , 1979, The American journal of medicine.

[492]  R. Fennell,et al.  Nephritis in systemic lupus erythematosus in children. , 1976, The Journal of pediatrics.

[493]  A. Sawalha,et al.  Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. , 2009, Translational research : the journal of laboratory and clinical medicine.

[494]  N. Goldenberg,et al.  Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. , 2009, Translational research : the journal of laboratory and clinical medicine.

[495]  L. Bachrach,et al.  Clinical review 1: Bisphosphonate use in childhood osteoporosis. , 2009, The Journal of clinical endocrinology and metabolism.

[496]  Z. N. D. de Oliveira,et al.  Discoid Lupus Erythematosus in Children—A Retrospective Study of 34 Patients , 2008, Pediatric dermatology.

[497]  C. Mohan,et al.  Genetic basis of murine lupus nephritis. , 2007, Seminars in nephrology.

[498]  S. Ajzen,et al.  Endothelial function analysis and atherosclerotic risk factors in adolescents with systemic lupus erythematosus , 2007, International journal of adolescent medicine and health.

[499]  Y. Ishigatsubo,et al.  Intestinal manifestations in systemic lupus erythematosus. , 2006, Internal medicine.

[500]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases BioMed Central Review , 2006 .

[501]  J. Ioannidis,et al.  Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. , 2006, Arthritis and rheumatism.

[502]  V. Cheng,et al.  Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. , 2006, QJM : monthly journal of the Association of Physicians.

[503]  L. Espinoza,et al.  Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus , 2005, Clinical Rheumatology.

[504]  N. Manolios,et al.  Evaluation of the BCL-2 gene locus as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus (SLE) , 2005, Rheumatology International.

[505]  M. McClain,et al.  Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry , 2005, Nature Medicine.

[506]  K. Kalunian,et al.  T-cell depletion improves outcome after autologous stem cell transplant in patients with systemic lupus erythematosus (SLE) , 2005, Bone Marrow Transplantation.

[507]  S. Izui,et al.  Genetic basis of murine lupus. , 2004, Autoimmunity reviews.

[508]  Marta E Alarcón-Riquelme,et al.  The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. , 2004, Arthritis and rheumatism.

[509]  H. Weelden,et al.  Light-induced skin lesions in lupus erythematosus: photobiological studies , 2004, Archives of Dermatological Research.

[510]  H. Papadaki.  Autoreactive T-lymphocytes are implicated in the pathogenesis of bone marrow failure in patients with systemic lupus erythematosus. , 2003, Leukemia & lymphoma.

[511]  Ricard Cervera,et al.  Clinical and epidemiological aspects in the antiphospholipid syndrome. , 2003, Immunobiology.

[512]  M. Ognjanović,et al.  Lupus nephritis in childhood: a review of 53 patients followed at a single center , 2003, Pediatric Nephrology.

[513]  M. Petri,et al.  High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. , 2003, Arthritis and rheumatism.

[514]  G. Hidalgo,et al.  Outcome in African-American children of neuropsychiatric lupus and lupus nephritis , 2002, Pediatric Nephrology.

[515]  I. Baumann,et al.  Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[516]  R. Klein,et al.  A longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases , 2000, Rheumatology International.

[517]  S. Waintraub,et al.  Use of anti-D in immune thrombocytopenic purpura as a means to prevent splenectomy: case reports from two University Hospital Medical Centers. , 2000, Seminars in hematology.

[518]  J. Ioannidis,et al.  Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. , 2000, Kidney international.

[519]  K. S. Lee,et al.  Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. , 2000, Journal of computer assisted tomography.

[520]  M. Reichlin,et al.  Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. , 1999, Arthritis and rheumatism.

[521]  E. Silverman,et al.  Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. , 1998, The Journal of pediatrics.

[522]  M. Gonzalez-gay,et al.  Fatal interstitial pneumonia due to cytomegalovirus following cyclophosphamide treatment in a patient with systemic lupus erythematosus. , 1998, Scandinavian journal of rheumatology.

[523]  Y. Shoenfeld,et al.  Central nervous system (CNS) involvement in SLE , 1998, Clinical reviews in allergy & immunology.

[524]  S. Trapani,et al.  Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density , 1998, Rheumatology International.

[525]  H. Hashimoto,et al.  Thrombocytopenia in systemic lupus erythematosus associated with cytomegalovirus infection. , 1997, Scandinavian journal of rheumatology.

[526]  M. Walport,et al.  Long-term management after splenectomy. Consider prophylaxis in systematic lupus erythematosus. , 1994, BMJ.

[527]  Y. Naparstek,et al.  Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin. , 1993, Acta haematologica.

[528]  K. David-Bajar.  Subacute cutaneous lupus erythematosus. , 1993, The Journal of investigative dermatology.

[529]  M. Babron,et al.  Antiphospholipid antibodies in patients with childhood onset systemic lupus erythematosus and their relatives. A French cooperative study. , 1992, Contributions to nephrology.

[530]  M. Doutre,et al.  Chilblain lupus erythematosus: report of 15 cases. , 1992, Dermatology.

[531]  M. Ng,et al.  Bone Marrow Findings in Lupus Patients with Pancytopenia , 1991, Pathology.

[532]  F. Furukawa,et al.  Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. , 1990, The Journal of investigative dermatology.

[533]  M. Lubani,et al.  Epidemiology of juvenile chronic arthritis and other connective tissue diseases among children in Kuwait. , 1990, Annals of tropical paediatrics.

[534]  B. Landing,et al.  Pathologic Features of Gastrointestinal Tract Lesions in Childhood-Onset Systemic Lupus Erythematosus , 1987 .

[535]  B. Landing,et al.  Pulmonary Lesions in Childhood Onset Systemic Lupus Erythematosus , 1987 .

[536]  A. Steinberg,et al.  Brain-reactive lymphocytotoxic antibody in the cerebrospinal fluid of patients with systemic lupus erythematosus: correlation with central nervous system involvement. , 1981, Clinical immunology and immunopathology.

[537]  R. Shadduck,et al.  Red‐cell hypoplasia and increased bone marrow reticulin in systemic lupus erythematosis: Reversal with corticosteroid therapy , 1978, American journal of hematology.

[538]  Stanley L. Lee,et al.  The epidemiology of systemic lupus erythematosus. , 1973, Seminars in arthritis and rheumatism.